Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico

References

• Chang Q, Tzeng YL, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol. 2012;4:1–10. doi:10.2147/CLEP.S28410.
   Google Scholar
• World Health Organization. Meningococcal vaccines: WHO position paper. Weekly Epidemiological Record. 2011;86. p. 521–540.
   Google Scholar
• Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(Suppl 2):B3–9. doi:10.1016/j.vaccine.2011.12.062.
   PubMed Web of Science ®Google Scholar
• Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397–403. doi:10.1016/S0140-6736(06)67932-4.
   PubMed Web of Science ®Google Scholar
• Vazquez JA, Taha MK, Findlow J, Gupta S, Borrow R. Global meningococcal initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease. Epidemiol Infect. 2016;144(14):3052–3057. doi:10.1017/S0950268816001308.
   PubMed Web of Science ®Google Scholar
• Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010;50(2):184–191. doi:10.1086/649209.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Meningococcal disease; 2020 [accessed 2021 Sep 10]. https://www.cdc.gov/meningococcal/surveillance/index.html.
   Google Scholar
• European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases; 2021 [accessed 2021 Sep 10]. https://ecdc.europa.eu/en/surveillance-atlas-infectious-diseases.
   Google Scholar
• Pelton SI. The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines. J Adolesc Health. 2016;59(2 Suppl):S3–S11. doi:10.1016/j.jadohealth.2016.04.012.
   PubMed Web of Science ®Google Scholar
• Vespa Presa J, Abalos MG, Sini de Almeida R, Cane A. Epidemiological burden of meningococcal disease in Latin America: a systematic literature review. Int J Infect Dis. 2019;85:37–48. doi:10.1016/j.ijid.2019.05.006.
   PubMed Web of Science ®Google Scholar
• Safadi MA, Cintra OA. Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol Res. 2010;32(3):263–271. doi:10.1179/016164110X12644252260754.
   PubMed Web of Science ®Google Scholar
• Vespa Presa J, de Almeida RS, Spinardi JR, Cane A. Epidemiological burden of meningococcal disease in Brazil: a systematic literature review and database analysis. Int J Infect Dis. 2019;80:137–146. doi:10.1016/j.ijid.2019.01.009.
   PubMed Web of Science ®Google Scholar
• Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J, Fermon F, Klugman KP, Ramsay M, Sow S, et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11(1):17. doi:10.1186/1478-7954-11-17.
   PubMed Web of Science ®Google Scholar
• Villena R, Valenzuela MT, Bastias M, Santolaya ME. Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction. Vaccine. 2022;40(4):666–672. doi:10.1016/j.vaccine.2021.11.075.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Control of epidemic meningitis in countries in the African meningitis belt, 2019. Weekly Epidemiological Rec 2020;95:133–144.
   Google Scholar
• Diaz J, Carcamo M, Seoane M, Pidal P, Cavada G, Puentes R, Terrazas S, Araya P, Ibarz-Pavon AB, Manriquez M et al. Prevalence of meningococcal carriage in children and adolescents aged 10-19 years in Chile in 2013. J Infect Public Health. 2016;9(4):506–515. doi:10.1016/j.jiph.2015.12.011.
   PubMed Web of Science ®Google Scholar
• Rodriguez P, Alvarez I, Torres MT, Diaz J, Bertoglia MP, Carcamo M, Seoane M, Araya P, Russo M, Santolaya ME. Meningococcal carriage prevalence in university students, 1824 years of age in Santiago, Chile. Vaccine. 2014;32(43):5677–5680. doi:10.1016/j.vaccine.2014.08.015.
   PubMed Web of Science ®Google Scholar
• López P, Gentile A, Ávila-Agüero ML, Efron A, Torres CN, Chacón E, Gabastou J-M, Brea J, Torres JP, Falleiros-Arlant LH, et al. Latin American forum on meningococcal disease, Latin American update: its prevention. Arch Pediatr. 2022;7:200.
   Google Scholar
• Pan American Health Organization. Frequently asked questions on meningococcal disease; 2021 [accessed 2022 Mar 1]. https://www.paho.org/en/documents/frequently-asked-questions-meningococcal-disease.
   Google Scholar
• Olbrich KJ, Muller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421–438. doi:10.1007/s40121-018-0213-2.
   PubMed Web of Science ®Google Scholar
• Rampakakis E, Vaillancourt J, Mursleen S, Sampalis JS. Healthcare resource utilization and cost of invasive meningococcal disease in Ontario, Canada. Pediatr Infect Dis J. 2019;38(3):253–257. doi:10.1097/INF.0000000000002251.
   PubMed Web of Science ®Google Scholar
• O’Brien JA, Caro JJ, and Getsios D. Managing meningococcal disease in the United States: hospital case characteristics and costs by age. Value Health. 2006;9(4):236–243. doi:10.1111/j.1524-4733.2006.00113.x.
   PubMed Web of Science ®Google Scholar
• Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Ostergaard L. Societal costs due to meningococcal disease: a national registry-based study. Clinicoecon Outcomes Res. 2018;10:563–572. doi:10.2147/CEOR.S175835.
   PubMed Web of Science ®Google Scholar
• Scholz S, Koerber F, Meszaros K, Fassbender RM, Ultsch B, Welte RR, Greiner W. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany. Vaccine. 2019;37(12):1692–1701. doi:10.1016/j.vaccine.2019.01.013.
   PubMed Web of Science ®Google Scholar
• Safadi MA, Gonzalez-Ayala S, Jakel A, Wieffer H, Moreno C, Vyse A. The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape. Epidemiol Infect. 2013;141(3):447–458. doi:10.1017/S0950268812001689.
   PubMed Web of Science ®Google Scholar
• Chacon-Cruz E, Sugerman DE, Ginsberg MM, Hopkins J, Hurtado-Montalvo JA, Lopez-Viera JL, Lara-Munoz CA, Rivas-Landeros RM, Volker ML, Leake JA. Surveillance for invasive meningococcal disease in children, US-Mexico border, 2005-2008. Emerg Infect Dis. 2011;17(3):543–546. doi:10.3201/eid1703.101254.
   PubMed Web of Science ®Google Scholar
• Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA. 1983;249(9):1181–1185. doi:10.1001/jama.1983.03330330059036.
   PubMed Web of Science ®Google Scholar
• Chacon Cruz E, Alvelais Palacios JA, Lopatynsky Reyes EZ, Rodriguez Valencia JA, Volker Soberanes ML. Meningococcal disease in children: eleven years of active surveillance in a Mexican hospital and the need for vaccination in the Tijuana region. J Infec Dis Treat. 2017;3(01):1–4. doi:10.21767/2472-1093.100031.
   Google Scholar
• Datosmacro C Expansión - México Salario minimo; 2020 [accessed 2021 Sep 10]. https://datosmacro.expansion.com/mercado-laboral/salario-medio/mexico.
   Google Scholar
• INEGI. Censo de Población y Vivienda; 2020 [accessed 2021 Sep 10]. https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2021/EstSociodemo/ResultCenso2020_BC.pdf.
   Google Scholar
• Sabin Vaccine Institute. Sizing up a killer: understanding meningococcal disease in Latin America 2021 [accessed 2021 Oct 2]. https://www.sabin.org/updates/blog/sizing-killer-understanding-meningococcal-disease-latin-america.
   Google Scholar
• Pan-American Health Organization. New study reveals significant healthcare system costs associated with meningococcal disease; 2012 [accessed 2021 Oct 2]. https://www3.paho.org/hq/index.php?option=com_content&view=article&id=6542:2012-importantes-costos-salud-asociados-meningococica&Itemid=135&lang=en.
   Google Scholar
• Constenla D, Carvalho A, Alvis Guzman N. Economic impact of meningococcal outbreaks in Brazil and Colombia. Open Forum Infect Dis. 2015;2(4):ofv167. doi:10.1093/ofid/ofv167.
   PubMedGoogle Scholar
• Wang B, Haji Ali Afzali H, Marshall H. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Vaccine. 2014;32(37):4791–4798. doi:10.1016/j.vaccine.2014.05.069.
   PubMed Web of Science ®Google Scholar
• World Bank. GDP per capita (current US$); 2020 [accessed 2022 Mar 1]. https://data.worldbank.org/indicator/NY.GDP.PCAP.CD.
   Google Scholar
• Barraza-Llorens M, Panopoulou G, Diaz BY. Income-Related inequalities and inequities in health and health care utilization in Mexico, 2000-2006. Rev Panam Salud Publica. 2013;33(2):122–130, 129 ppreceding 122. doi:10.1590/s1020-49892013000200007.
   PubMed Web of Science ®Google Scholar
• Urquieta-Salomon JE, Villarreal HJ. Evolution of health coverage in Mexico: evidence of progress and challenges in the Mexican health system. Health Policy Plan. 2016;31(1):28–36. doi:10.1093/heapol/czv015.
   PubMed Web of Science ®Google Scholar
• Padron F. Meningitis meningocóccica en los niños. Rev Med Hosp Central San Luis Potosi. 1949;1:193–218.
   Google Scholar
• Almeida-Gonzalez L, Franco-Paredes C, Perez LF, Santos-Preciado JI. Meningococcal disease caused by Neisseria meningitidis: epidemiological, clinical, and preventive perspectives. Salud Publica Mex. 2004;46(5):438–450. doi:10.1590/s0036-36342004000500010.
   PubMed Web of Science ®Google Scholar
• Harrison LH. Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis. 2010;50(Suppl 2):S37–44. doi:10.1086/648963.
   PubMed Web of Science ®Google Scholar
• Chacon-Cruz E, Espinosa-De Los Monteros LE, Navarro-Alvarez S, Aranda-Lozano JL, Volker-Soberanes ML, Rivas-Landeros RM, Alvelais-Arzamendi AA, Vazquez JA. An outbreak of serogroup C (ST-11) meningococcal disease in Tijuana, Mexico. Ther Adv Vaccines. 2014;2(3):71–76. doi:10.1177/2051013614526592.
   PubMedGoogle Scholar
• Figueroa-Lara A, Gonzalez-Block MA, Alarcon-Irigoyen J. Medical expenditure for chronic diseases in Mexico: the case of selected diagnoses treated by the largest care providers. PLoS One. 2016;11(1):e0145177. doi:10.1371/journal.pone.0145177.
   PubMed Web of Science ®Google Scholar
• Mould-Quevedo JF, Contreras-Hernández I, Martínez-Valverde S, Villasis-Keever MA, Granados-García VM, Salinas-Escudero G, Muñoz-Hernández O. Direct medical costs of treating Mexican children under 2 years of age with respiratory syncytial virus. Bol Med Hosp Infant Mex. 2012;69:111–115.
   Google Scholar